253 related articles for article (PubMed ID: 35630075)
1. Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration.
Kubicka-Trząska A; Żuber-Łaskawiec K; Dziedzina S; Sanak M; Romanowska-Dixon B; Karska-Basta I
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630075
[No Abstract] [Full Text] [Related]
2. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
[TBL] [Abstract][Full Text] [Related]
3. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD).
Mohamad NA; Ramachandran V; Ismail P; Mohd Isa H; Chan YM; Ngah NF; Md Bakri N; Ching SM; Hoo FK; Wan Sulaiman WA; Inche Mat LN; Hazmi Mohamed M
Bosn J Basic Med Sci; 2018 Aug; 18(3):260-267. PubMed ID: 29579408
[TBL] [Abstract][Full Text] [Related]
5. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M
Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095
[TBL] [Abstract][Full Text] [Related]
6. Investigation of genetic base in the treatment of age-related macular degeneration.
Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
[TBL] [Abstract][Full Text] [Related]
7. Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis.
Hong N; Shen Y; Yu CY; Wang SQ; Tong JP
Acta Ophthalmol; 2016 Jun; 94(4):334-45. PubMed ID: 27151934
[TBL] [Abstract][Full Text] [Related]
8. CFH Y402H and VEGF Polymorphisms and Anti-VEGF Treatment Response in Exudative Age-Related Macular Degeneration.
Kepez Yildiz B; Ozdek S; Ergun MA; Ergun S; Yaylacioglu Tuncay F; Elbeg S
Ophthalmic Res; 2016; 56(3):132-8. PubMed ID: 27404493
[TBL] [Abstract][Full Text] [Related]
9. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
Brantley MA; Fang AM; King JM; Tewari A; Kymes SM; Shiels A
Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
[TBL] [Abstract][Full Text] [Related]
10. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis.
Roshanshad A; Moosavi SA; Arevalo JF
Ophthalmic Res; 2024; 67(1):358-386. PubMed ID: 38754401
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variants rs641153 (
Neto JM; Viturino MG; Ananina G; Bajano FF; Costa SMDS; Roque AB; Borges GF; Franchi R; Rim PH; Medina FM; Costa FF; Melo MB; de Vasconcellos JP
Exp Biol Med (Maywood); 2021 Nov; 246(21):2290-2296. PubMed ID: 34233521
[TBL] [Abstract][Full Text] [Related]
12. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population.
Medina FMC; Motta AALD; Takahashi WY; Carricondo PC; Motta MMDS; Melo MB; Vasconcellos JPC
Ophthalmic Res; 2019; 61(3):168-173. PubMed ID: 28641277
[TBL] [Abstract][Full Text] [Related]
13. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population.
Chu J; Zhou CC; Lu N; Zhang X; Dong FT
Chin Med J (Engl); 2008 Dec; 121(24):2525-33. PubMed ID: 19187590
[TBL] [Abstract][Full Text] [Related]
15. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
[TBL] [Abstract][Full Text] [Related]
16. Gene polymorphisms associated with an increased risk of exudative age-related macular degeneration in a Spanish population.
Gili P; Lloreda Martín L; Martín-Rodrigo JC; Kim-Yeon N; Modamio-Gardeta L; Fernández-García JL; Rebolledo-Poves AB; Gómez-Blazquez E; Pazos-Rodriguez R; Pérez-Fernández E; Velasco M
Eur J Ophthalmol; 2022 Jan; 32(1):651-657. PubMed ID: 33765843
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
[TBL] [Abstract][Full Text] [Related]
18. Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD.
Kloeckener-Gruissem B; Barthelmes D; Labs S; Schindler C; Kurz-Levin M; Michels S; Fleischhauer J; Berger W; Sutter F; Menghini M
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4694-702. PubMed ID: 21282580
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.
Nischler C; Oberkofler H; Ortner C; Paikl D; Riha W; Lang N; Patsch W; Egger SF
Acta Ophthalmol; 2011 Jun; 89(4):e344-9. PubMed ID: 21232084
[TBL] [Abstract][Full Text] [Related]
20. Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population.
Cui L; Zhou H; Yu J; Sun E; Zhang Y; Jia W; Jiao Y; Snellingen T; Liu X; Lim A; Wang N; Liu N
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1116-20. PubMed ID: 19850835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
